DTE Energy Co

Recent news

• Shenzhen Kangtai Biological Products: The adsorbed acellular DTP (component) combination vaccine has commenced Phase III clinical trials.
  Breakings · 2025/5/30
• China's first three-component DTP vaccine approved, marking a significant growth milestone for CanSino Biologics.
  Gelonghui Finance · 2026/4/14
• Company notice
  Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- A.N.P TRUST #18 THOMAS DTP
  SEC · 2025/8/16
• Company notice
  Hyatt Hotels | 3: Initial statement of beneficial ownership of securities- DON G.C. Trust #1 DTP
  SEC · 2025/6/7
• Company notice
  Hyatt Hotels | 3: Initial statement of beneficial ownership of securities- A.N.P TRUST #18 THOMAS DTP
  SEC · 2025/6/7
• Company Q&A | CanSino: The company has laid out plans and is continuously advancing the overseas rollout of its DTP (diphtheria, tetanus, and pertussis) vaccine series portfolio.
  Gelonghui Finance · 2026/4/14
• Zhifei Biological: Clinical trial application for the acellular DTP vaccine for adolescents and adults has been accepted.
  Breakings · 2025/8/18
• Chongqing Pharmaceutical Holdings (000950.SZ): The company's DTP prescription pharmacy business has shown overall positive development.
  Gelonghui Finance · 2025/12/18
• Company notice
  Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- DON G.C. Trust #1 DTP
  SEC · 2025/8/16
• Company notice
  Hyatt Hotels | 4: Statement of changes in beneficial ownership of securities- R.A. G.C. Trust #1 DTP
  SEC · 2025/8/16

Headlines are aggregated automatically and are not independently verified or edited by our team.